Next report date
Report period
Q1 2024
EPS estimate
−0.14USD
Revenue estimate
800.00 KUSD
−0.7610USD
−59.49 MUSD
1.68 MUSD
52.80 M
About Akili, Inc.
Sector
Industry
CEO
Matthew Franklin
Website
Headquarters
Boston
Founded
2020
FIGI
BBG0119BNH27
Akili, Inc. is a digital medicine company, which engages in the development of cognitive treatments through technologies. Its technologies are designed to directly target the physiology of the brain. The company was founded by W. Edward Martucci II and Adam Gazzaley in December 2020 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AKLI is 0.2416 USD — it has decreased by 2.60% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Akili, Inc. stocks are traded under the ticker AKLI.
Akili, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
AKLI stock is 8.23% volatile and has beta coefficient of 1.10. Check out the list of the most volatile stocks — is Akili, Inc. there?
AKLI earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.22 USD resulting in a 16.92% surprise. The estimated earnings for the next quarter are −0.21 USD per share. See more details about Akili, Inc. earnings.
Akili, Inc. revenue for the last quarter amounts to 702.00 K USD despite the estimated figure of 323.00 K USD. In the next quarter revenue is expected to reach 800.00 K USD.
Yes, you can track Akili, Inc. financials in yearly and quarterly reports right on TradingView.
AKLI stock has risen by 13.88% compared to the previous week, the month change is a 15.84% fall, over the last year Akili, Inc. has showed a 77.21% decrease.
AKLI net income for the last quarter is −11.15 M USD, while the quarter before that showed −15.88 M USD of net income which accounts for 29.79% change. Track more Akili, Inc. financial stats to get the full picture.
Today Akili, Inc. has the market capitalization of 19.49 M, it has increased by 1.91% over the last week.
No, AKLI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AKLI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Akili, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Akili, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Akili, Inc. stock shows the sell signal. See more of Akili, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Akili, Inc. EBITDA is −64.18 M USD, and current EBITDA margin is −3.82 K%. See more stats in Akili, Inc. financial statements.